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Photodynamic therapy (PDT) is a cancer treatment involving
the irradiation of tissues that have been sensitized by a photo-
sensitizing agent. A recent approach to PDT involves the use of
5-aminolaevulinic acid (ALA) to induce the endogenous synthesis
of protoporphyrin IX (PpIX); its clinical use has been recently
reviewed by Peng et al (1997).
The extent to which ALA-induced photosensitization is selec-
tive depends on the rates of synthesis and metabolism of PpIX
(Fukuda et al, 1992). ALA-induced PpIX accumulation has been
shown in some cases to be preferentially greater in tumour cells
primarily due to the reduced activity of ferrochelatase, the enzyme
catalysing the incorporation of ferrous iron (Van Hillegersberg
et al, 1992), and a relative enhancement of deaminase activity
(Navone et al, 1990).
In vitro evidence suggests that the enzymes of the haem
synthetic pathway are constitutively expressed with the exception
of ALA synthase, which regulates porphyrin production by
modifying the intracellular availability of ALA (Washbrook et al,
1997). Exposure of cells to an external source of ALA results in
enhanced porphyrin synthesis and the accumulation of PpIX.
This accumulation of porphyrin is increased by inhibition of
ferrochelatase, which can be brought about by the use of iron
chelators (Berg et al, 1996).
Some iron chelators such as desferrioxamine (Ortel et al, 1993),
EDTA (Hanania et al, 1992) and 2,2¢-dipyridyl (Walter et al, 1997)
have been investigated in order to enhance the quantity of PpIX
produced from ALA application with some good results. Ortho-
phenantholine has also been employed (Rebeiz et al, 1992).
It has been previously found that the hydroxypyridinone iron
chelator, 1,2-diethyl-3-hydroxypyridin-4-one (CP94), enhanced
porphyrin fluorescence and photosensitivity in cell lines (Bech
et al, 1997), as well as doubling the PpIX content in the urothelium
of normal bladder (Chang et al, 1997) and normal colon mucosa of
rats, inducing an increased area of necrosis after PDT (Curnow
et al, 1998).
Uptake of ALA from extracellular sources is an important deter-
minant of PpIX accumulation. The mechanism of cellular uptake
is not clear in eukaryotic cells, but some transporter mechanism is
inferred (Washbrook et al, 1997; Correa Garcia et al, 1998). Entry
by diffusion may be limited by the hydrophilic nature of ALA.
Therefore, derivatives rendered more hydrophobic by the addition
of lipophilic moieties which can be cleaved by intracellular
enzymes have been investigated as pro-drugs.
Some lipophilic molecules, such as esterified ALA derivatives,
have been used both in human basal cell carcinomas (Peng et al,
1995), in nude mouse skin (Peng et al, 1996) and in human tumour
cell lines (Gaullier et al, 1997), and a higher and more homo-
geneous tissue distribution was produced, compared to those of
free ALA-induced porphyrins. In addition, Kloek et al (1996,
1998) demonstrated both in cell lines and in animal models that
several ALA pro-drugs are capable of being taken up, de-esterified
and converted into PpIX with higher efficiency than ALA itself.
However, Washbrook and Riley (1997) and Gaullier et al (1997)
found in vitro that ALA-methyl ester (ALA-Me) is less effective
than ALA at inducing the synthesis of PpIX.
The aim of this paper is to evaluate by ex-vivo fluorescence,
employing skin explants, the capacity of the chelator CP94 and
several esterified ALA derivatives of enhancing PpIX synthesis.
MATERIALS AND METHODS
Chemicals
ALA powder, ALA-Me (Sigma Chemical Co.) and ALA-hexyl
ester (ALA-He) were dissolved in saline. All other ALA deriva-
tives were dissolved in dimethyl sulphoxide (DMSO). The iron
chelator CP94 was synthesized according to the procedure of
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Pharmacy. King’s College, London and used in a concentration of
100 mg ml–1 (equivalent to 0.6 mM).
Synthesis of ALA derivatives
Novel ALA derivatives are depicted in Figure 1, and were synthe-
sized as follows.
ALA-He was prepared according to the method of Takeya
(1992) by reacting ALA with hexanol in the presence of thionyl
chloride giving the compound as the hydrochloride (HCl) salt.
ALA1–4 were synthesized according to the method of Tanaka
et al (1993). The benzyl ester of ALA was prepared by reacting
ALA with benzyl alcohol in the presence of thionyl chloride. This
was then reacted with the appropriate freshly distilled acid
chloride (N-butanoyl,  N-pentanoyl,  N-hexanoyl or N-heptanoyl
chloride) in pyridine. The benzyl ester was removed by hydro-
genation using 10% palladium on activated charcoal as a catalyst.
ALA5–7 were prepared by reacting a Z-protected amino acid
with an ester of ALA using N-cyclohexyl-3,2-morpholinoethyl
carbodiimide metho p-toluene sulphonate in DCM as a coupling
agent.
ALA8 was prepared by reacting N-phthalimidolaevulinic acid
with glucosamine tetraacetate using the same coupling agent as for
ALA5–7.  N-phthalimidolaevulinic acid was prepared using a
method adapted from Iida et al (1998). Tetrahydrofurfuryl chloride
was reacted with potassium phthalimide for 3 h (cf. the original
method in which tetrahydrofurfuryl bromide was reacted for 1 h)
giving N-tetrahydrofurfuryl phthalimide. N-phthalimidolaevulinic
acid (ALA11) was obtained by oxidation using sodium metaperio-
date and ruthenium (III) chloride n-hydrate in aqueous acetonitrile
and 1,1,2-trichloro-1,2,2-trifluoroethane, a safer substitute for
carbon tetrachloride. Glucosamine tetraacetate was prepared using
the four-step procedure of Bergmann and Zervas (1932). The
amine of glucosamine hydrochloride was first protected using
anisaldehyde and acetylation was achieved with acetic anhydride
in pyridine. The anisole group was removed with HCl in aqueous
acetone and the free amine was released from its HCl salt using
sodium methoxide.
ALA9 was prepared by the reaction of ALA with formaldehyde
in the presence of hydrogen gas and 10% Pd/C catalyst in water.
ALA10 was synthesized using the method of Kloek and
Beijersbergen van Henegouwen (1996) using ALA, acetic
anhydride in the presence of triethylamine.
ALA11 was prepared as for ALA8.
Animal and human skin samples
Animal skin samples were obtained from normal, female Wistar
rats (120–200 g) 2 months old. The animals were sacrificed by
asphyxia, their skin shaved and excised with scissors, the adipose
layer removed and kept on ice until used. Fresh white human skin
samples mainly from the breast or abdomen were obtained from
cosmetic surgical excisions.
Skin explant cultures
The explant tissue culture system developed by Polo et al (1988)
was used. Skin explants of about 70–100 mg were floated in
2.5 ml of serum-free Dulbecco’s modified Eagle’s medium
(DMEM)–F-12 medium without phenol red, containing 50 IU ml–1
penicillin and 50 mg ml–1 streptomycin. Incubations were
performed in the presence of ALA with or without CP94, or ALA
derivatives dissolved in DMSO at 37°C in an atmosphere of
humidified air with 5% carbon dioxide in the dark. Control
explants incubated in the absence of ALA, and in the presence of
DMSO and CP94 alone were performed.
PpIX content
Direct tissue fluorescence of the epidermal surface was measured
with a plate fluorescence reader (Perkin-Elmer, UK) connected to
a Perkin-Elmer LS 50B fluorescence spectrophotometer using
410 nm excitation and 635 nm emission with slit widths set to 10
nm both on the excitation and emission monochromators, and an
internal 530 nm highpass filter used on the emission side; spectral
scans were made between 650 and 780 mm to check for the pres-
ence of other porphyrins. Intensity calibrations were performed
using a standard of rhodamine B embedded in a Perspex disc. It
was shown that fluorescence values were proportional to
porphyrin concentration, extracted following the procedure
detailed below. Appropriate controls for each specimen were
included.
Spectral identification of porphyrin species
Fluorescence emission spectra from chemically extracted
porphyrins were recorded using the Perkin-Elmer LS 50B fluor-
escence spectrophotometer (Perkin-Elmer, UK) using 410 nm
excitation. Protoporphyrin, uroporphyrin I and coproporphyrin I
methyl esters (Porphyrin Products, Logan, UT, USA) were used
as standards.
The tissue samples were homogenized in a 4:1 solution of ethyl
acetate–glacial acetic acid. The homogenates were centrifuged for
30 min at 3000 g and the supernatants extracted with 5% HCl until
the aliquots showed no fluorescence. This procedure extracts over
85% of porphyrins in tissue samples. Porphyrins in the medium
were extracted with the same ethyl acetate–acetic acid and HCl
procedure. Direct emission spectra of tissue and media porphyrins
were also recorded using 410 nm excitation.
CCD fluorescence microscopy
For recording of fluorescence micrographs skin explants were
frozen and 10-mm-thick cryosections were prepared, together with
adjacent sections for haematoxylin and eosin staining. A technique
combining phase contrast microscopy and a slow-scan charge
coupled device (CCD) camera (Wright Instruments Ltd, Enfield,
London, UK) was used. The fluorescence was excited using an
8 mW helium–neon laser (632.8 nm) and detected between 665
and 710 nm using bandpass and longpass filters as described
previously (Bedwell et al, 1992). A false-colour-coded image of
the fluorescence intensity was quantified digitally by averaging
over-specified areas. The slow scan CCD system permitted highly
reproducible signal calibration. Because the cryosections were of
variable quality no quantitative analysis was attempted. Sections
of material incubated with ALA, ALA-Me and ALA-He, with and
without CP94 were examined.
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Statistical analysis of data was performed by Student’s t-test. Data
are reported as mean ± s.d. Changes were considered significant
when P < 0.05.
RESULTS
Spectral identification of porphyrin species
Fluorescence emission spectra of porphyrins extracted from rat
skin incubated in the presence of ALA exhibited peaks at 606 and
661 nm coinciding with those of the PpIX standard (Figure 2A).
Coproporphyrin and uroporphyrin were excreted into the
medium (Figure 2B) both by human and rat explants exposed to
either ALA or its derivatives. The percentage of porphyrins
released into the medium was 20% of the total porphyrin synthe-
sized between 2 and 19 h of incubation.
The direct fluorescence emission spectra of explants exposed to
ALA (Figure 2C) were characteristic of PpIX with peak emission
at 635 and 710 nm as previously demonstrated (Iinuma et al,
1994).
The direct fluorescence spectrum of medium (Figure 2D)
showed two prominent peaks at 581 and 616 nm, one of which has
been ascribed to hydrophobic porphyrins by Dietel et al (1996),
but we have not identified the products.
Medium incubated in the presence of ALA without tissue
behaved as control explants incubated without ALA, and no
porphyrin peaks were found.
In both rat and human skin explants incubated with ALA-Me,
ALA-He and ALA plus CP94, direct or extracted porphyrins
showed similar emission spectra to those illustrated in Figure 2A
and C, although with differing fluorescence intensities. Similarly,
their corresponding medium profiles were similar to those shown
in Figure 2B and D.
PpIX production in skin exposed to ALA, ALA-He and
ALA-Me
As Figure 3 illustrates, the levels of rat tissue PpIX after exposure
to 0.6 mM ALA increased linearly with time over the 19-h incuba-
tion period. Conversely, exposure to either methyl or hexyl deriva-
tives led to a maximum on PpIX synthesis after 5 h of incubation.
Nevertheless, 19 h was the time selected for the analysis of
concentration-dependence, because human skin exhibited low
fluorescence levels at shorter incubation periods (data not shown).
Figure 4A shows that both ALA and ALA-He in rat skin induce
maximal PpIX accumulation between 0.6 and 1.2 mM, whereas
Porphyrin synthesis from ALA derivatives in skin organ culture 1527
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Figure 1 Structures of ALA and the derivatives. 1: N-butanoyl-5-ALA; 2: N-pentyl-5-ALA; 3: N-hexanoyl-5-ALA; 4: N-heptanoyl-5-ALA; 5: carbobenzoyloxy-
glycinyl-5-ALA-hexyl ester; 6: carbobenzoyloxy-D-phenylalanyl-5-ALA-ethyl ester; 7: carbobenzoyloxy-glycinyl-5-ALA-ethyl ester; 8: N-phthalylimido-5-ALA-
glucosamine-tetraacetate; 9: N,N-dimethyl-5-ALA; 10: N-acetyl-5-ALA and 11: N-phthalylimido-5-ALA. Compounds 1, 2, 3, 4, 9 and 10 were obtained as the
corresponding hydrochloric acid saltsmaximal PpIX fluorescence was reached on incubation of tissue
with 2 mM ALA-Me.
Figure 4B shows that in human skin explants, synthesis of PpIX
is not saturated by ALA or its derivatives within the range of
concentrations tested. In both rat and human skin explants ALA is
most effective at inducing PpIX fluorescence at low concentra-
tions of substrate (0.2 and 0.6 mM respectively), but the methyl
ester appears to have a greater inducing effect (P = 0.01 at higher
concentrations – 2 mM). The hexyl ester sample gave significantly
lower values than ALA (P = 0.001) at this concentration. Since
time courses were not determined for each of the derivatives tested
it may be that some of these differences reflect differences in the
pattern of uptake as well as relative rates.
PpIX production by ALA derivatives
In the study of the methyl- and hexyl-ALA effects on PpIX
synthesis a number of other ALA derivatives were examined (see
Figure 1). Compounds 1, 2, 8 and 11 failed totally to induce PpIX
fluorescence and in the case of 1 and 2 they appeared to have toxic
effects resulting in lower values than in control skin. The effects of
the remaining compounds on rat and human skin explants at three
concentrations are summarized in Table 1.
In general, the degree of PpIX induction was less than the corre-
sponding effect of ALA with the exception of compound 6, which
exhibited a marginal increase in rat skin (P = 0.001 at 0.6 mM
concentration) and levels similar to ALA controls in human skin
and slightly higher at 2 mM concentration (P = 0.04).
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Figure 2 Fluorescence emission spectra of porphyrins in rat skin and medium. Left panels: fluorescence spectra of skin (A) and medium (B) after chemical
extraction. Solid lines, explant incubated in the presence of 0.6 mM ALA; dashed line, PpIX standard in HCl; dotted line, Coproporphyrin standard in HCl; dash-
dotted line, Uroporphyrin standard in HCl. Right panels: direct emission spectra of skin (C) and medium (D). Dashed lines, explant incubated in the presence of
0.6 mM ALA for 5 h; solid lines, explant incubated for 5 h without ALACP94 enhancement of PpIX production
Figure 5A shows that the simultaneous exposure of rat skin
explants to 0.6 mM ALA and CP94 results in a slight increase in
PpIX fluorescence (P = 0.016 at 200 mg ml–1) but in human skin
explants (Figure 5B) exposure to CP94 substantially increases the
PpIX yield reaching a maximum of about eightfold at 300 mg ml–1.
This effect was also observed at higher ALA concentrations
although it was less marked, for example, using 300 mg ml–1 CP94,
130% and 80% increases of PpIX were obtained on exposure of
explants to 1.2 and 2 mM ALA respectively (data not shown).
Moreover, CP94 elevated human skin PpIX production in presence
of 1.2 mM ALA-He by sixfold and 50% on exposure to 2 mM
ALA-Me.
Controls incubated in the presence of CP94 without ALA exhib-
ited fluorescence values equal to those obtained in the absence of
the iron chelator. CP94 addition to cultures did not elevate the
percentage of release of hydrophilic porphyrins into the medium in
any of the conditions studied.
Fluorescence microscopy
Figure 6 shows CCD images of fluorescence in human skin
explants after 19 h incubation with the hexyl ester derivative
(ALA-He) at 1.2 mM with 0.6 mM CP94 and, for comparison,
1.2 mM ALA alone. In all the sections examined the fluorescence
is highest in the epidermis. In rat skin a similar biodistribution
was observed, although fluorescence associated with hair follicles
was more evident than in the human samples. Autofluorescence
was only detectable in the stratum corneum.
Porphyrin synthesis from ALA derivatives in skin organ culture 1529
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Figure 3 PpIX fluorescence after exposure of rat skin explants to 0.6 mM
ALA (n n), ALA-He ( ) and ALA-Me ( ) for 2, 3, 5 and 19 h. Direct skin
fluorescence was measured at 410 nm excitation and 635 nm emission, and
autofluorescence of explants incubated without ALA was subtracted. The
bars show the means of four independent experiments performed in
duplicate. Error bars show standard deviations. Asterisks denote P < 0.05.
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Figure 4 PpIX fluorescence after 19 h exposure of rat (A) and human skin (B) to different concentrations of ALA (n n), ALA-He ( ) and ALA-Me ( ). Direct
skin fluorescence was measured at 410 nm excitation and 635 nm emission, and autofluorescence of explants incubated without ALA was subtracted. The bars
show the means of four independent experiments performed in duplicate. Error bars show standard deviations. One asterisk indicates P < 0.01 and two,
P < 0.001 compared to the corresponding ALA concentrationDISCUSSION
As can be seen from emission spectra of extracted porphyrins, the
fluorescent species present in the samples was consistent with
PpIX. Uroporphyrin, coproporphyrin and the various carboxylated
intermediates are released into the medium by skin explants when
incubated without serum (Fukuda et al, 1989). Under our condi-
tions, no PpIX was fluorimetrically distinguished in the incubation
media.
PpIX production as a function of ALA concentration was linear,
which is consistent with earlier observations on mouse skin
explants (Fukuda et al, 1989). The time-course of PpIX induction
in the case of the methyl or hexyl esters may be affected by differ-
ence in diffusion through the dermis by the more hydrophobic
compounds and may account for the more homogeneous distribu-
tion observed. The concentration dependence (Figure 4) may
reflect the efficiency of conversion of the precursors to ALA by
tissue esterases so that higher concentrations are required to
release equivalent amounts of ALA. The greater effect on PpIX
fluorescence in human skin explants of the methyl ester at high
concentration may be due to a diminished rate of degradation.
Topical administration of ALA esters (Peng et al, 1995, 1996)
leads to a higher PpIX yield than that produced by the same dose
of free ALA, but the factors involved are unclear.
In our work we found that higher ALA-Me concentrations are
required to achieve the PpIX levels obtained by free ALA. These
results agree with those of Washbrook and Riley (1997), who
found that in hepatocyte cultures exposed to equimolar concentra-
tions of ALA and ALA-Me, the latter was less effective at
inducing the synthesis of PpIX, and are also in accordance with the
results of Gaullier et al (1997). With the exception of the high-
dosage methyl ester of ALA and compound 6, none of the deriva-
tives examined were as active as ALA in inducing PpIX
fluorescence. In the case of four of the derivatives no porphyrin
production was observed. This may have been the result of some
unrelated toxic action, perhaps due to its hydrophobic release of
1530 A Casas et al
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Table 1 PpIX induced by ALA derivatives
Rat Human
ALA
0.6 mM 5.67 ± 0.43 5.83 ± 0.98
1.2 mM 6.80 ± 1.31 16.87 ± 3.45
2m M 3.25 ± 0.48 21.15 ± 5.40
ALA 3
0.6 mM 0.35 ± 0.52 0.09 ± 0.11
1.2 mM 1.09 ± 0.09 0.15 ± 0.11
2m M 1.00 ± 0.60 0.41 ± 0.24
ALA 4
0.6 mM 2.25 ± 1.31 0.03 ± 0.08
1.2 mM 1.40 ± 0.90 0.01 ± 0.20
2m M 4.38 ± 0.01 0.39 ± 0.16
ALA 5
0.6 mM 1.18 ± 0.78 0.22 ± 0.04
1.2 mM 2.40 ± 0.82 0.24 ± 0.09
2m M 3.23 ± 1.53 0.41 ± 0.22
ALA 6
0.6 mM 7.81 ± 0.95 2.87 ± 0.83
1.2 mM 7.33 ± 0.95 8.60 ± 1.59
2m M 6.57 ± 3.12 29.60 ± 5.26
ALA 7
0.6 mM 1.75 ± 0.86 0.67 ± 0.25
1.2 mM 4.81 ± 0.76 2.83 ± 0.93
2m M 5.56 ± 1.25 10.36 ± 2.28
ALA 9
0.6 mM 0.51 ± 0.09 0.08 ± 0.22
1.2 mM 1.92 ± 0.65 0.06 ± 0.26
2m M 2.91 ± 0.78 0.24 ± 0.07
ALA 10
0.6 mM 0.96 ± 0.12 0.02 ± 0.09
1.2 mM 2.87 ± 2.19 0.16 ± 0.09
2m M 1.43 ± 0.58 0.21 ± 0.39
Rat and human skin explants were incubated for 19 h in the presence of 0.6,
1.2 and 2 mM of ALA and ALA derivatives. In order to compare data, ALA
was dissolved in DMSO in this experiment. PpIX fluorescence is expressed
as arbitrary units measured at 410 nm excitation and 635 nm emission, and
subtracting autofluorescence of explants from the same tissue sample
incubated without ALA. Averages ± s.d. of three independent experiments
performed in duplicate are shown.
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Figure 5 PpIX fluorescence after 2 h exposure of rat (A) and human (B) skin to 0.6 mM ALA in the presence of different amounts of CP94 in the incubation
media. Direct skin fluorescence was measured at 410 nm excitation and 635 nm emission, and autofluorescence of explants incubated without ALA was
subtracted. The bars show the means of four independent experiments performed in duplicate. Error bars show standard deviations. Asterisks indicate P < 0.05short-chain carboxylic acids or the inability of the enzymes in the
tissue to liberate the ALA from the pro-drug as in the case of the
Mannich complexes or difficulties in their actual uptake.
In the remaining cases the efficiency of PpIX induction appears
to differ between rat and human skin. In part the different thick-
ness of the dermis may account for differences in diffusion,
although in some instances (e.g. compounds 9 and 10) these are
likely to be small. Modifications of stability of the ALA precursors
should also be taken into account although the complexes are
likely to be more susceptible to degradation than ALA itself.
Nevertheless, the major factor would appear to be the effectiveness
and tissue distribution of the ALA uptake and release mechanisms.
Because the initial step in the PpIX synthesis from ALA or its
derivatives is their penetration through the plasma membrane, as
indicated above, another very important parameter to be consid-
ered is the transmembrane transport of ALA and the extent to
which the derivatives are capable of being translocated into the
cytosol. This could be the rate-limiting step since most hydrolytic
enzymes are located intracellularly. It is likely that the uptake of
ALA and ALA derivatives might proceed by different mecha-
nisms. The mechanism of ALA transport in human cells is not yet
clear, but it has been well characterized in yeast (Bermudez
Moretti et al, 1995). It would therefore be of interest to know
whether ALA derivatives diffuse passively across the plasma
membrane or have other active transport mechanisms similar or
different from ALA.
At present it is not clear which enzymes might be involved in
the liberation of ALA although in the case of compounds 3 and 4
and the methyl and hexyl esters it is likely that non-specific
esterases are implicated and, in the case of compounds 5, 6 and 7 it
may be that proteases are responsible for the release.
It is worthy of note that the explant culture system has been a
useful and simple tool for testing ex-vivo the ability of organs to
synthesize PpIX from ALA (Fukuda et al, 1989; Fritsch et al,
1997). Using floating explant cultures, the drugs are absorbed
through the dermis to reach the epidermis, resembling the systemic
pathway of drug delivery.
It is known that PpIX accumulation is enhanced by inhibition of
ferrochelatase (Van Hilligersberg et al, 1992). CP94 is a powerful
iron chelator which diminishes incorporation of iron into PpIX to
form haem and may also inhibit the chelatase. Bech et al (1997)
have shown in a cell culture system that CP94 markedly increases
the yield of PpIX in cells exposed to ALA in the case of low ALA
concentrations. In the experiments reported here we show that
CP94 has a similar action in the case of human skin explants.
Thus, the addition of CP94 may prove a useful method of
increasing the sensitivity of PpIX bioassays as well as having
possible clinical implications, as indicated by the results of
Curnow et al (1998).
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